The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism
NCT00451672 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2007-03-23
Summary
we propose that bromocriptine may be an alternative treatment of primary aldosteronism, both APA and BAH.
Conditions
- Hyperaldosteronism
- Hypertension
Interventions
- DRUG
-
bromocriptine
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Kwan-Dun Wu, MD, PhD · Internal Medicine, Natinal Taiwan University Hospital
-
Vin-Cent Wu, MD · Internal Medicine, National Taiwan University Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Completion
- 2007-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Mutation Analysis of 17βhydroxysteroid Dehydrogenase 3 Deficiency
NCT00173654 ·Status: UNKNOWN
-
Studies of Apolipoprotein Genotyping on the Drug Treatment of Hyperlipidemic Patients
NCT00451464 ·Status: COMPLETED
-
Primary Aldosteronism in Malaysia: A Nationwide Multicentre Study
NCT02257450 ·Status: UNKNOWN
-
The Relation Between Serum Level of Amioterminal Propeptide of Type I Procollagen and Diastolic Dysfunction in Hypertensive Patients Without Diabetes Mellitus
NCT00172406 ·Status: COMPLETED
-
Epidemiology, Management, Prognosis and Medical Cost Analysis of IHCA and OHCA
NCT03684616 ·Status: COMPLETED
-
Effect of Flow Rate and PH on Muscle Acidosis
NCT05165277 ·Status: TERMINATED ·Phase: NA
-
Outcome Analysis of Endoscopic Resection of Pituitary Adenomas
NCT06156020 ·Status: RECRUITING ·Phase: NA
-
Angiotensinogen Gene and Hypertension
NCT00173004 ·Status: UNKNOWN
-
Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men
NCT02088164 ·Status: COMPLETED
-
The Application of Serum DNA Methylation for Patients With HCC
NCT05764551 ·Status: RECRUITING ·Phase: NA
-
Adiponectin Gene and Coronary Artery Disease
NCT00172991 ·Status: UNKNOWN
-
Methylation Biosignature in Childhood Chronic Kidney Disease
NCT02022046 ·Status: COMPLETED
-
Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary Hypertension
NCT00173537 ·Status: UNKNOWN ·Phase: NA
-
Developing a Simple Recognition System of Acromegaly
NCT03042026 ·Status: RECRUITING
-
Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization
NCT07178093 ·Status: RECRUITING ·Phase: NA
-
Angiotensin Converting Enzyme Gene Polymorphism in Children With Idiopathic Nephrotic Syndrome
NCT00172276 ·Status: COMPLETED
-
The Prevalence and Characteristics of Adrenal Incidentaloma
NCT04682938 ·Status: COMPLETED
-
Association Between Cortisol, Cortisone, Cotinine, Nicotine, Caffeine, Melatonin Levels in Hair, Serum, Urine, Saliva and Chronic Stress
NCT02403921 ·Status: UNKNOWN
-
Newborn Screening for Adrenoleukodystrophy
NCT02952482 ·Status: COMPLETED
-
Catecholamines Can Attenuate Intermittent Hypoxia-Induced Expression of TNF in Human Monocytes
NCT00498862 ·Status: UNKNOWN
-
Cohort Study of Adrenogenic Autonomic Cortisol Secretion
NCT05743933 ·Status: NOT_YET_RECRUITING
-
Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan
NCT00867633 ·Status: UNKNOWN
-
Characterization of Macroprolactinemia
NCT00436111 ·Status: COMPLETED
-
A Retrospective Study for Multiple Endocrine Neoplasia
NCT05812573 ·Status: UNKNOWN
-
Effects of Low Protein Formula on Renal Function, Oxidative Stress and Antioxidant Capacities in CKD Patients
NCT01999023 ·Status: UNKNOWN ·Phase: NA